Urinary Incontinence Clinical Trial
Official title:
Predictor of Early Recovery on Urinary Continence After Laparoscopic Radical Prostatectomy: Bladder Neck Level and the Association With Urodynamic Parameters
To investigate the relationship between post-operative bladder neck levels and urodynamic parameters and their effect on urinary incontinence after laparoscopic radical prostatectomy (LRP). Forty-eight consecutive patients undergoing LRP were retrospectively reviewed. All patients had investigated by retrograde cystography after LRP and were grouped according their bladder neck position: Level 0: bladder neck at or above the superior margin of the symphysis pubis (SMSP), Level -1: bladder neck at <2 cm below SMSP, and Level -2: bladder neck at >2 cm below SMSP. Urodynamic studies were carried out at baseline, 3 and 6 months post-operatively. Early recovery of urinary continence was defined as no urine leakage or only one pad/day used within 3 months after surgery. Demographic characteristics, changes of urodynamic parameters and continence outcomes were analyzed.
Laparoscopic radical prostatectomy (LRP) is effective in treating localized prostate cancer
with good long-term oncological outcomes. Urinary incontinence, which is a bothersome
complication with a negative effect on the patient's quality of life, remains a relevant
problem after LRP, despite the improvements in the surgical technique. More than 80% of
patients undergoing radical prostatectomy encounter urinary incontinence immediately after
catheter removal, but the bladder condition can generally stabilize within two years after
operation. Among the patients undergoing LRP, persistent urinary incontinence has been
reported in 4−30% of patients, and further treatment is often required.
Definite evaluation for the voiding function has been recommended for patients with
prolonged post-prostatectomy urinary incontinence (PPI). To improve quality of life after
LRP, early recovery of urinary continence is an important concern for patients. Several
studies have investigated the predictive factors of early recovery of urinary continence
after prostatectomy, including the amount of urine loss after catheter removal, pelvic floor
muscle function, a nerve-sparing technique, and the membranous urethral length loss ratio.
Other factors relating to the early recovery of urinary continence include post-operative
anatomy of the lower urinary tract, such as the length of the membranous urethra and the
level of the vesicourethral junction. However, there has been no consensus on the standard
criteria that should be used to measure the structural changes, and the relationship between
the urodynamic change and the anatomical morphology remains unclear. In this study,
investigators study the relationship between the urodynamic parameters and the bladder neck
levels after LRP, and their effects on the early recovery of urinary incontinence.
This study was a retrospective analysis. From 2011 to 2014, a total of 48 consecutive
patients with localized prostatic cancer underwent LRP in single medical center by two
experienced surgeons. Videourodynamic study was performed before operation (baseline) and at
3 and 6 months after operation. The Ethics Committee of the hospital approved this study and
written informed consent was waived because the study was a retrospective analysis. The
principles of Helsinki Declaration were followed throughout the study.
The urodynamic parameters were measured and recorded including first sensation of filling
(FSF), maximum flow rate (Qmax), detrusor pressure at Qmax (PdetQmax), voided volume,
cystometric bladder capacity (CBC), bladder compliance, post-void residual (PVR) volume,
maximal urethral closure pressure (MUCP) and functional profile length (FPL). The urodynamic
parameters were compared between baseline and different time-points after LRP.
The BN level was evaluated by retrograde cystography, which was routinely performed 7 to 14
days after LRP to evaluate the condition of anastomosis. The image was obtained
anteroposteriorly after infusing 100-150 mL of contrast solution into the bladder while the
patient was in standing position. The distance between the bladder neck and the superior
margin of the symphysis pubis (SMSP) was then measured by the same urologist. The bladder
neck level was graded on a three-point scale: a bladder neck level at or above the SMSP was
marked as level 0, a bladder neck level with a distance less than 2 cm below the SMSP was
marked as level -1, and bladder neck levels 2 or more cm below the SMSP was labeled as level
-2.
The patient's urinary continence status was evaluated on direct visits and via
questionnaires during follow-up periods at 3, 6, and 12 months post-operatively. Patients
without urine leakage in their daily life and those who used only one pad per day for safety
reasons without limitation in their daily activities were defined as "urinary continent".
Otherwise, the patients were defined as "urinary incontinent". Regaining continence within 3
months after LRP was considered early recovery of urinary continence.
The data was collected retrospectively by chart review. The variables among continent and
incontinent patients were evaluated by univariate analysis (t-test for continuous variables
and Chi-square for categorical variables ). The ANOVA test was use to compare the urodynamic
parameters between different BN levels. Statistical analysis was performed using SPSS 20.0
statistical software.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05534412 -
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
|
N/A | |
| Recruiting |
NCT05515198 -
Improving Care for Women With Urinary Incontinence (EMPOWER)
|
N/A | |
| Completed |
NCT04071301 -
Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence
|
N/A | |
| Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
| Recruiting |
NCT05880862 -
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls
|
Early Phase 1 | |
| Recruiting |
NCT04159467 -
Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet
|
N/A | |
| Completed |
NCT05485922 -
Performance of a Single-use Intermittent Micro-hole Zone Catheter
|
N/A | |
| Completed |
NCT06268782 -
The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women
|
N/A | |
| Not yet recruiting |
NCT03027986 -
Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy
|
N/A | |
| Recruiting |
NCT02490917 -
ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence
|
N/A | |
| Enrolling by invitation |
NCT02529371 -
Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients
|
N/A | |
| Enrolling by invitation |
NCT02530372 -
Feasibility of the UriCap-F for Urine Collection in Hospitalized Women
|
N/A | |
| Completed |
NCT02338726 -
Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study
|
N/A | |
| Completed |
NCT02549729 -
Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy
|
N/A | |
| Completed |
NCT02600676 -
Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis
|
N/A | |
| Completed |
NCT02239796 -
Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence
|
N/A | |
| Completed |
NCT02368262 -
Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy
|
N/A | |
| Completed |
NCT01942681 -
Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride
|
N/A | |
| Recruiting |
NCT01804153 -
Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)
|
Phase 1/Phase 2 | |
| Completed |
NCT01520948 -
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
|
Phase 3 |